在治疗布罗苏马布期间,两名患有X结合性低酸血症的儿科患者的三级性甲状腺功能增强症
Raja Padidela1, Lauren Rayner2, Annemieke M Boot3
1Department of Paediatric Endocrinology, Manchester University NHS Foundation Trust Hospital, Manchester, UK; Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
带有高血症的三级甲状腺功能障碍症是小儿X链接低血症 (XLH) 患者接受Burosumab治疗的罕见并发症. 在这些患者中,密切监测二级和三级甲状腺功能障碍症至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 遗传学和遗传性疾病
- 代谢性骨疾病 代谢性骨疾病
背景情况:
- 与X相关的低酸血症 (XLH) 是一种罕见的遗传疾病,影响酸盐和维生素D的代谢.
- 二次性甲状腺功能增强症是接受治疗的XLH患者已知的并发症.
- 在儿科XLH患者中,三级甲状腺功能增强症与高热血症异常罕见.
研究的目的:
- 报告了两例儿科XLH患者的病例,他们在接受Burosumab治疗时出现过高血症的三级甲状腺功能障碍症.
- 要强调这种并发症的罕见发生情况,并强调需要保持警的监测.
主要方法:
- 两名患有XLH的女性儿科患者的病例报告.
- 在传统治疗 (酸盐和活性维生素D) 之后,患者接受了布罗苏马布治疗.
- 记录了临床过程,实验室值和治疗结果,包括副甲状腺切除术和药物调整.
主要成果:
- 这两名患者在接受Burosumab治疗期间都出现了带有高血的三级性甲状腺功能过高症.
- 在这两种情况下,手术管理 (副甲状腺切除术) 导致高血症的解决.
- 由于PTH波动,一名患者需要在手术后持续使用Cinacalcet治疗.
结论:
- 在这些接受布罗苏马布治疗的XLH患者中,三级甲状腺功能障碍的确切原因尚不清楚.
- 潜在的触发因素包括剂量后酸盐水平升高或PHEX突变对副甲状腺的直接影响.
- 定期监测二次和三次性偏甲状腺功能障碍症对于小儿XLH患者接受Burosumab治疗至关重要.
更多相关视频
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
07:12Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
相关概念视频
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
